Colin Geddes - Concepedia

Author

Colin Geddes

Western Infirmary ORCID

Also Known As

Agnes Fogo, Amit Garg, C C Geddes, C GEDDES, C Geddes, C. C Geddes, C. C. Geddes, C. G. Geddes, C. GEDDES, C. Geddes

231

Publications

9.8K

Citations

H-Index

Concepts

All Affiliations

Western Infirmary University of Glasgow Queen Elizabeth University Hospital Glasgow Royal Infirmary Leicester General Hospital

About

Colin Geddes is an author at Western Infirmary specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	2.1K
2	Public Health	5	6	306
3	Health Sciences	2	2	67
4	Engineering	1	1	38
5	Anesthesia	1	1	34

Colin Geddes

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
The MEST score provides earlier risk prediction in lgA nephropathy Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich, Kidney International Mest ScoreGlomerulonephritisMedicineKidney FailureLupus Nephritis	2015	279
Early Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure Jamie P. Traynor, Keith Simpson, Colin Geddes, Journal of the American Society of Nephrology	2002	239
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy P. N. Harden, P. A. Rowe, R.S.C Rodger, The Lancet Glomerular DiseaseGlomerulonephritisMedicineGeneticsRenal Pathology	1995	222
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults Rosanna Coppo, Stéphan Troyanov, Roberta Camilla, Kidney International Glomerular DiseaseRheumatologyGlomerulonephritisUrologyRenal Disease	2010	204
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203
The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study Michel Jadoul, J.-L. Poignet, Colin Geddes, Nephrology Dialysis Transplantation	2004	187
A tricontinental view of IgA nephropathy Colin Geddes Nephrology Dialysis Transplantation	2003	187
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events F Mindlen, Roberto Nordaby, M I Soto Ruiz, Queensland's institutional digital repository (The University of Queensland) Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials	1996	154
Acute kidney injury: outcomes and quality of care Emma Aitken, Christina Carruthers, Le Gall, QJM	2013	121

Page 1